Open main menu

Pages with the fewest revisions

Showing below up to 250 results in range #101 to #350.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 62‏‎ (1 revision)
  2. Stochastic effect‏‎ (1 revision)
  3. ICRP Publication 77‏‎ (1 revision)
  4. Equilibrium factor‏‎ (1 revision)
  5. Tolerance dose‏‎ (1 revision)
  6. 1950 Recommendations‏‎ (1 revision)
  7. Occupancy factor‏‎ (1 revision)
  8. Backscatter factor‏‎ (1 revision)
  9. ICRP Publication 10A‏‎ (1 revision)
  10. ICRP Publication 123‏‎ (1 revision)
  11. Charged-particle equilibrium‏‎ (1 revision)
  12. Radon-prone area‏‎ (1 revision)
  13. ICRP Publication 138‏‎ (1 revision)
  14. Collimation‏‎ (1 revision)
  15. Reference Person‏‎ (1 revision)
  16. ICRP Publication 152‏‎ (1 revision)
  17. Relative life lost‏‎ (1 revision)
  18. ICRP Publication 27‏‎ (1 revision)
  19. ICRP Publication 99‏‎ (1 revision)
  20. ICRP Publication 33‏‎ (1 revision)
  21. Detriment-adjusted risk‏‎ (1 revision)
  22. Security screening‏‎ (1 revision)
  23. ICRP Publication 48‏‎ (1 revision)
  24. Dose-response function‏‎ (1 revision)
  25. International Commission on Radiological Protection‏‎ (1 revision)
  26. ICRP Publication 63‏‎ (1 revision)
  27. Lag‏‎ (1 revision)
  28. ICRP Publication 78‏‎ (1 revision)
  29. Elemental dose‏‎ (1 revision)
  30. Teratocarcinoma‏‎ (1 revision)
  31. Low dose‏‎ (1 revision)
  32. Exposed individuals‏‎ (1 revision)
  33. 1954 Recommendations‏‎ (1 revision)
  34. Apoptosis‏‎ (1 revision)
  35. Potentially lethal damage repair‏‎ (1 revision)
  36. ICRP Publication 11‏‎ (1 revision)
  37. ICRP Publication 124‏‎ (1 revision)
  38. ICRP Publication 139‏‎ (1 revision)
  39. ICRP Publication 153‏‎ (1 revision)
  40. Relative risk‏‎ (1 revision)
  41. ICRP Publication 28‏‎ (1 revision)
  42. Ring chromosome‏‎ (1 revision)
  43. ICRP Supporting Guidance 2‏‎ (1 revision)
  44. ICRP Publication 34‏‎ (1 revision)
  45. ICRP Publication 49‏‎ (1 revision)
  46. Source region‏‎ (1 revision)
  47. ICRP Publication 64‏‎ (1 revision)
  48. Late normal tissue responses‏‎ (1 revision)
  49. ICRP Publication 79‏‎ (1 revision)
  50. 1956 Recommendations‏‎ (1 revision)
  51. Activation‏‎ (1 revision)
  52. Α/β value‏‎ (1 revision)
  53. Oncogene‏‎ (1 revision)
  54. ICRP Publication 1‏‎ (1 revision)
  55. Baseline disease rates‏‎ (1 revision)
  56. ICRP Publication 110‏‎ (1 revision)
  57. Breakpoint cluster region/abelson‏‎ (1 revision)
  58. ICRP Publication 125‏‎ (1 revision)
  59. ICRP Publication 14‏‎ (1 revision)
  60. Commissioning‏‎ (1 revision)
  61. ICRP Publication 154‏‎ (1 revision)
  62. Cosmic radiation‏‎ (1 revision)
  63. Relative survival‏‎ (1 revision)
  64. ICRP Publication 29‏‎ (1 revision)
  65. ICRP Publication 35‏‎ (1 revision)
  66. ICRP Publication 5‏‎ (1 revision)
  67. Dose-threshold hypothesis‏‎ (1 revision)
  68. Intervention‏‎ (1 revision)
  69. ICRP Publication 65‏‎ (1 revision)
  70. Sublethal damage repair‏‎ (1 revision)
  71. ICRP Publication 8‏‎ (1 revision)
  72. Transfer of risk‏‎ (1 revision)
  73. Molecular imaging‏‎ (1 revision)
  74. 1959 Decisions‏‎ (1 revision)
  75. Noise‏‎ (1 revision)
  76. ΓH2AX foci‏‎ (1 revision)
  77. Operating management‏‎ (1 revision)
  78. Pencil beam‏‎ (1 revision)
  79. Hereditary effect‏‎ (1 revision)
  80. Practice‏‎ (1 revision)
  81. ICRP Publication 10‏‎ (1 revision)
  82. ICRP Publication 111‏‎ (1 revision)
  83. ICRP Publication 126‏‎ (1 revision)
  84. ICRP Publication 140‏‎ (1 revision)
  85. ICRP Publication 155‏‎ (1 revision)
  86. ICRP Publication 3‏‎ (1 revision)
  87. ICRP Publication 36‏‎ (1 revision)
  88. Dicentric chromosome‏‎ (1 revision)
  89. Severe deterministic injury‏‎ (1 revision)
  90. ICRP Publication 50‏‎ (1 revision)
  91. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  92. ICRP Publication 66‏‎ (1 revision)
  93. Licensee‏‎ (1 revision)
  94. ICRP Publication 80‏‎ (1 revision)
  95. Thermodynamic diameter‏‎ (1 revision)
  96. Low linear energy transfer radiation‏‎ (1 revision)
  97. Nominal risk coefficient‏‎ (1 revision)
  98. Active detection system‏‎ (1 revision)
  99. ICRP Publication 100‏‎ (1 revision)
  100. Quality control testing‏‎ (1 revision)
  101. ICRP Publication 112‏‎ (1 revision)
  102. Radioactive waste‏‎ (1 revision)
  103. ICRP Publication 127‏‎ (1 revision)
  104. ICRP Publication 141‏‎ (1 revision)
  105. ICRP Publication 16‏‎ (1 revision)
  106. ICRP Publication 30‏‎ (1 revision)
  107. Dental and maxillofacial imaging‏‎ (1 revision)
  108. Risk model‏‎ (1 revision)
  109. ICRP Publication 37‏‎ (1 revision)
  110. Sheltering‏‎ (1 revision)
  111. Induced genomic instability‏‎ (1 revision)
  112. ICRP Publication 51‏‎ (1 revision)
  113. ICRP Publication 67‏‎ (1 revision)
  114. Doubling dose‏‎ (1 revision)
  115. Superposition principle‏‎ (1 revision)
  116. Life Span Study‏‎ (1 revision)
  117. ICRP Publication 81‏‎ (1 revision)
  118. Thoracic airways‏‎ (1 revision)
  119. Evacuation‏‎ (1 revision)
  120. Multifactorial diseases‏‎ (1 revision)
  121. Exposure index‏‎ (1 revision)
  122. AML/eto‏‎ (1 revision)
  123. Nominal value‏‎ (1 revision)
  124. Frequent flyer‏‎ (1 revision)
  125. Attributable risk‏‎ (1 revision)
  126. ICRP Publication 101‏‎ (1 revision)
  127. Best available techniques‏‎ (1 revision)
  128. ICRP Publication 113‏‎ (1 revision)
  129. Bronchiolar region‏‎ (1 revision)
  130. ICRP Publication 128‏‎ (1 revision)
  131. ICRP Publication 142‏‎ (1 revision)
  132. Compartment‏‎ (1 revision)
  133. ICRP Publication 17‏‎ (1 revision)
  134. Count median diameter‏‎ (1 revision)
  135. ICRP Publication 30 (Index)‏‎ (1 revision)
  136. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  137. ICRP Publication 38‏‎ (1 revision)
  138. Shielding‏‎ (1 revision)
  139. ICRP Publication 52‏‎ (1 revision)
  140. Dose commitment‏‎ (1 revision)
  141. ICRP Publication 68‏‎ (1 revision)
  142. Supervised area‏‎ (1 revision)
  143. ICRP Publication 82‏‎ (1 revision)
  144. Thoron progeny‏‎ (1 revision)
  145. Excess absolute risk‏‎ (1 revision)
  146. Transgenerational effect‏‎ (1 revision)
  147. Exposure pathway‏‎ (1 revision)
  148. Non-homologous end joining‏‎ (1 revision)
  149. Functional subunits‏‎ (1 revision)
  150. Activity median aerodynamic diameter‏‎ (1 revision)
  151. Optimisation of protection‏‎ (1 revision)
  152. Ground-level enhancement‏‎ (1 revision)
  153. ICRP Publication 101a‏‎ (1 revision)
  154. Quasi-threshold dose‏‎ (1 revision)
  155. ICRP Publication 114‏‎ (1 revision)
  156. ICRP Publication 129‏‎ (1 revision)
  157. Radon progeny‏‎ (1 revision)
  158. ICRP Publication 143‏‎ (1 revision)
  159. Compartment (environmental)‏‎ (1 revision)
  160. Reference parameter value‏‎ (1 revision)
  161. ICRP Publication 18‏‎ (1 revision)
  162. Cross section‏‎ (1 revision)
  163. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  164. Deposition‏‎ (1 revision)
  165. ICRP Publication 39‏‎ (1 revision)
  166. Digital breast tomosynthesis‏‎ (1 revision)
  167. ICRP Publication 53‏‎ (1 revision)
  168. Specific absorbed fraction‏‎ (1 revision)
  169. ICRP Publication 69‏‎ (1 revision)
  170. Surface contamination‏‎ (1 revision)
  171. ICRP Publication 83‏‎ (1 revision)
  172. Translocation‏‎ (1 revision)
  173. Multistage carcinogenesis model‏‎ (1 revision)
  174. Phantom‏‎ (1 revision)
  175. Homologous recombination‏‎ (1 revision)
  176. Authorised discharge‏‎ (1 revision)
  177. ICRP Publication 101b‏‎ (1 revision)
  178. ICRP Publication 115‏‎ (1 revision)
  179. ICRP Publication 13‏‎ (1 revision)
  180. Clinical audit‏‎ (1 revision)
  181. Ras‏‎ (1 revision)
  182. ICRP Publication 144‏‎ (1 revision)
  183. Reference phantom‏‎ (1 revision)
  184. ICRP Publication 19‏‎ (1 revision)
  185. ICRP Publication 90‏‎ (1 revision)
  186. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  187. ICRP Publication 4‏‎ (1 revision)
  188. Size-specific dose estimate‏‎ (1 revision)
  189. ICRP Publication 54‏‎ (1 revision)
  190. ICRP Publication 7‏‎ (1 revision)
  191. ICRP Publication 84‏‎ (1 revision)
  192. Threshold level‏‎ (1 revision)
  193. Exclusion‏‎ (1 revision)
  194. Acute exposure‏‎ (1 revision)
  195. Organ at risk‏‎ (1 revision)
  196. Allometry‏‎ (1 revision)
  197. Principles of protection‏‎ (1 revision)
  198. ICRP Publication 102‏‎ (1 revision)
  199. Radiation-induced second cancer‏‎ (1 revision)
  200. ICRP Publication 116‏‎ (1 revision)
  201. ICRP Publication 130‏‎ (1 revision)
  202. Rb‏‎ (1 revision)
  203. ICRP Publication 145‏‎ (1 revision)
  204. Reference value‏‎ (1 revision)
  205. ICRP Publication 2‏‎ (1 revision)
  206. ICRP Publication 91‏‎ (1 revision)
  207. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  208. Derived consideration reference level‏‎ (1 revision)
  209. ICRP Publication 40‏‎ (1 revision)
  210. Slice‏‎ (1 revision)
  211. ICRP Publication 55‏‎ (1 revision)
  212. Dose conversion convention‏‎ (1 revision)
  213. Spongiosa‏‎ (1 revision)
  214. ICRP Publication 70‏‎ (1 revision)
  215. Effect modifier‏‎ (1 revision)
  216. ICRP Publication 85‏‎ (1 revision)
  217. Endosteum‏‎ (1 revision)
  218. Marrow cellularity‏‎ (1 revision)
  219. Multitarget equation‏‎ (1 revision)
  220. Pilomatricoma‏‎ (1 revision)
  221. Biological half-life‏‎ (1 revision)
  222. Radiation-induced secondary malignancy‏‎ (1 revision)
  223. ICRP Publication 117‏‎ (1 revision)
  224. Radiological attack‏‎ (1 revision)
  225. ICRP Publication 131‏‎ (1 revision)
  226. Reactive oxygen species‏‎ (1 revision)
  227. ICRP Publication 146‏‎ (1 revision)
  228. Concentration ratio‏‎ (1 revision)
  229. Reference worker‏‎ (1 revision)
  230. ICRP Publication 20‏‎ (1 revision)
  231. ICRP Publication 92‏‎ (1 revision)
  232. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  233. Derived investigation level‏‎ (1 revision)
  234. ICRP Publication 41‏‎ (1 revision)
  235. Directional dose equivalent‏‎ (1 revision)
  236. Informed consent‏‎ (1 revision)
  237. ICRP Publication 56‏‎ (1 revision)
  238. Dose conversion factor‏‎ (1 revision)
  239. ICRP Publication 71‏‎ (1 revision)
  240. System of radiological protection‏‎ (1 revision)
  241. ICRP Publication 86‏‎ (1 revision)
  242. Time-resolved computed tomography‏‎ (1 revision)
  243. Mutation component‏‎ (1 revision)
  244. Waste management‏‎ (1 revision)
  245. Normal tissue complication probability‏‎ (1 revision)
  246. Human Alimentary Tract Model‏‎ (1 revision)
  247. ICRP Publication 104‏‎ (1 revision)
  248. Biomarker‏‎ (1 revision)
  249. Radiological controlled area‏‎ (1 revision)
  250. ICRP Publication 132‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)